IRIS
FOSCHI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.830
AS - Asia 2.233
EU - Europa 1.373
SA - Sud America 744
AF - Africa 71
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.257
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.697
SG - Singapore 1.053
BR - Brasile 616
IT - Italia 418
HK - Hong Kong 387
RU - Federazione Russa 286
CN - Cina 271
VN - Vietnam 234
DE - Germania 161
FI - Finlandia 103
NL - Olanda 85
IN - India 72
GB - Regno Unito 67
CA - Canada 63
FR - Francia 57
MX - Messico 54
AR - Argentina 51
AT - Austria 46
EC - Ecuador 33
ID - Indonesia 30
PL - Polonia 30
ES - Italia 26
JP - Giappone 26
SE - Svezia 26
ZA - Sudafrica 26
BD - Bangladesh 25
IQ - Iraq 21
IE - Irlanda 15
TR - Turchia 15
IR - Iran 14
AE - Emirati Arabi Uniti 13
CO - Colombia 11
ET - Etiopia 11
UZ - Uzbekistan 11
CL - Cile 10
PY - Paraguay 10
SA - Arabia Saudita 10
PK - Pakistan 9
UA - Ucraina 8
LT - Lituania 7
MA - Marocco 7
VE - Venezuela 7
DZ - Algeria 6
IL - Israele 6
KZ - Kazakistan 6
TN - Tunisia 6
BE - Belgio 5
CH - Svizzera 5
MY - Malesia 5
RO - Romania 5
TH - Thailandia 5
AU - Australia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
PE - Perù 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
KR - Corea 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AF - Afghanistan, Repubblica islamica di 2
CG - Congo 2
GA - Gabon 2
GD - Grenada 2
GT - Guatemala 2
JM - Giamaica 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
AL - Albania 1
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
HR - Croazia 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RW - Ruanda 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.257
Salva come PNG Salva come JPEG
Città #
Dallas 2.293
Singapore 535
Hong Kong 380
Santa Clara 217
Ashburn 193
Boardman 155
New York 86
Hefei 78
Ho Chi Minh City 78
Los Angeles 78
Moscow 62
São Paulo 53
Munich 52
Hanoi 42
Lappeenranta 42
The Dalles 35
Verona 35
Beijing 34
Helsinki 33
Mexico City 30
Council Bluffs 28
Montreal 28
L’Aquila 27
Rio de Janeiro 26
Warsaw 26
Milan 25
Turku 25
Shanghai 22
Stockholm 22
West Jordan 22
Frankfurt am Main 20
Rome 20
Denver 19
Benevento 18
Curitiba 18
Düsseldorf 18
Tokyo 18
Brooklyn 16
Nuremberg 16
Haiphong 15
Orem 15
Chennai 14
Guayaquil 14
Johannesburg 14
Poplar 14
Atlanta 13
Bologna 13
Boston 13
London 13
Vienna 13
Ankara 12
Brasília 12
Dublin 12
Toronto 12
Amsterdam 11
Da Nang 11
Kitzingen 11
Phoenix 11
Spoltore 11
Tashkent 11
Chandler 10
Chicago 10
Falkenstein 10
Taizhou 10
Campinas 9
Jakarta 9
Salvador 9
Assago 8
Belo Horizonte 8
Charlotte 8
Ha Long 8
Manchester 8
Thái Bình 8
Changsha 7
Houston 7
Naples 7
Pescara 7
Porto Alegre 7
Quito 7
Columbus 6
Fortaleza 6
Hải Dương 6
Mumbai 6
New Delhi 6
Palermo 6
Querétaro 6
Ribeirão Preto 6
Seattle 6
St Louis 6
São José dos Campos 6
Thái Nguyên 6
Turin 6
Baghdad 5
Biên Hòa 5
Buenos Aires 5
Huế 5
Montes Claros 5
Pontedera 5
Portsmouth 5
Ravenna 5
Totale 5.465
Salva come PNG Salva come JPEG
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 324
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis 314
Coronary Artery Disease and Atherosclerosis in Other Vascular Districts: Epidemiology, Risk Factors and Atherosclerotic Plaque Features 285
Implementing Blood Biomarkers in Stroke Research and Clinical Practice 280
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years 263
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 201
High-Density Lipoprotein Cholesterol Levels and their impact on outcomes in acute ischemic stroke patients treated with mechanical thrombectomy 198
Persistent progression independent of relapse activity in multiple sclerosis 176
Age‐Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 143
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 125
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage 123
C-Reactive Protein elevation and subsequent atrial fibrillation detection after ischemic stroke treated with mechanical thrombectomy: an inverse probability weighting analysis 122
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 116
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 106
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 105
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 100
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 90
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 87
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 87
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 87
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 78
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 78
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis 77
Outcomes of Mechanical Thrombectomy in Patients With Ischemic Stroke and Heart Failure. A Systematic Review and Meta‐analysis 71
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 70
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 69
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis 69
Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke 67
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 67
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 66
Do antithrombotic drugs have a role in migraine prevention? A systematic review 65
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 64
Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials 63
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 63
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 62
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 60
Antithrombotic treatment of cervical arterial dissection: Big data needed to inform long-term management 60
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 59
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 59
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study 58
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 57
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 57
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 55
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 55
The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre study 55
The Italian Multiple Sclerosis Register Experience With Cladribine 54
Switch from fingolimod to ozanimod for safety or intolerance reasons 54
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 53
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 53
Impact of Sex on Clinical Outcomes of Tandem Occlusion in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy. A Propensity‐Matched Analysis 53
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 53
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 53
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 52
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 52
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 52
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 52
Identifying Cladribine prescription pattern in MS: an Italian multicentre study 51
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study 51
How far are we from bringing intensive care bundle for intracerebral hemorrhage into the real-world setting? A 5-year population based-study 50
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 50
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 50
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 49
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 49
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024) 48
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 47
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 47
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 46
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 46
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 45
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 45
Impact of Atrial Fibrillation on Outcomes in Stroke Patients with Tandem Occlusions Treated with Thrombectomy.A multicentre study 44
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 44
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 44
“NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab” 43
Annual level changes of serum neuronal and glial biomarkers in a German professional football club 43
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 42
Stress hyperglycemia is associated with futile recanalization in patients with anterior large vessel occlusion undergoing mechanical thrombectomy 42
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 41
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 41
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 40
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 39
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 39
Another Nail in the Coffin of Causality for the Diastolic Blood Pressure J Curve 38
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 37
A call for academic pragmatic clinical trials to address open questions in migraine prevention 37
Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review 37
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 36
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 36
Clinicoradiological Profile and Functional Outcome of Acute Cerebral Venous Thrombosis: A Hospital-Based Cohort Study 35
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 35
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 34
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable 33
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic 33
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 33
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation 32
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 32
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 32
Comparison of Drip‐and‐Ship Versus Mothership Delivery Models of Mechanical Thrombectomy Delivery 32
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 32
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 31
Totale 7.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024391 6 10 16 47 22 47 3 3 3 85 63 86
2024/20252.742 106 28 195 99 229 178 292 205 629 259 264 258
2025/20265.194 277 2.307 793 1.073 564 180 0 0 0 0 0 0
Totale 8.428